Gedeon Richter and Mithra have expanded their partnership on an in-development contraceptive, Estelle, to cover several Latin American territories on top of Europe and Russia.
Gedeon Richter and Mithra Pharmaceuticals have added several “key markets” in Latin America to a licensing deal for the in-development Estelle (estetrol/drospirenone) 15mg/3mg oral contraceptive that Richter has already licensed for Europe and Russia.
According to the latest agreement, Richter will distribute Mithra’s product in Chile, Colombia, Ecuador, Mexico and Peru, with an option...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
